🏛️ SEBI PMS Overhaul Consultation Paper — Portfolio Manager Revamp
SEBI has issued a comprehensive consultation paper (Jul 23, 2026) seeking public comments by August 13, 2026 on a major overhaul of the SEBI (Portfolio Managers) Regulations, 2020. The draft Portfolio Managers Regulations, 2026 propose significant liberalization and structural changes.
Key Proposals
| Proposal | Detail |
|---|---|
| Overseas Investment | Allow PMS to invest in specified foreign securities subject to conditions |
| Unlisted Debt | Allow limited investment in investment-grade unlisted debt for discretionary PMS |
| MF-PMS Framework | New Mutual Fund-only PMS category with reduced entry thresholds |
| Derivatives Flexibility | Greater flexibility for exchange-traded derivatives in PMS |
| Compliance Simplification | Relaxed dealing room requirements for PMS with <10 clients or AUM <₹100cr |
| Demat Portability | Allowing demat account portability for PMS clients |
| Digital Disclosures | Enhanced digital disclosure requirements |
📊 Indian Market Snapshot — July 29, 2026
Sensex: 77,654.60 (+888.68, +1.16%) | Nifty: 24,250.20 (+264.85, +1.10%) | Nifty IT: 31,194.75 (+2.55%)
The Indian market staged a powerful rebound despite mixed global cues, led by IT stocks and financials. Key movers:
| Sector | Performance | Lead Stocks |
|---|---|---|
| IT | +1.70% (+16-19% in July) | INFY +4.50%, TCS, HCLTECH |
| Metals & Mining | +2.43% | Strong global demand signals |
| FMCG | +1.55% | HUL +4.70% (Q1 results beat) |
| Pharma | +1.16% | DIVISLAB +5.23% |
| Fin/Nifty IT | +2.55% | Fourth straight session gain |
| Energy & Oil | -0.13% | Crude volatility persists |
| Realty | -1.13% | Profit booking |
NSE F&O Action: NSE removed Exide Industries and Nuvama Wealth from F&O segment effective July 29 as per SEBI's stricter derivatives eligibility criteria. Indigo, Jubilant Foodworks, BHEL, Alkem saw elevated rollover interest.
Stocks to Watch
| Stock | Impact | Reason |
|---|---|---|
| MOTILALOFS | 🟢 BUY | Direct PMS player. Regulatory liberalization (overseas investment, MF-PMS, derivatives flexibility) expands addressable market. Confidence: 4/5 |
| HDFCAMC | 🟢 BUY | AMC beneficiary of MF-PMS framework. Wealth management tailwind. Confidence: 3/5 |
| NIPPONLIFE | 🟢 BUY | Large AMC with PMS ambitions. New categories expand AUM potential. Confidence: 3/5 |
| BSE | 🟡 HOLD | Exchange benefits from increased PMS activity/volumes. Indirect beneficiary. Confidence: 3/5 |
| ANGELONE | 🟡 HOLD | Broking volumes may benefit from increased PMS activity, but competitive pressure. Confidence: 2/5 |
| INFY | 🟢 BUY | Q1 results beat expectations (+4.50% today). IT rally leader. Nifty IT +2.55%. Confidence: 4/5 |
| TCS | 🟢 BUY | IT sector tailwind, reverse AI trade rotation. Confidence: 4/5 |
| HCLTECH | 🟢 BUY | IT momentum + FII stake cuts reversed by July rally. Confidence: 3/5 |
| HUL | 🟢 BUY | Q1 revenue +10% YoY (best in 13 quarters). +4.70% today. FMCG turnaround. Confidence: 4/5 |
| KAYNES | 🟢 BUY | +12.46% today. Infrastructure/semiconductor theme. Momentum strong. Confidence: 3/5 |
| DIVISLAB | 🟢 BUY | +5.23% today. Pharma sector rotation. Generic drug tariff uncertainty may push rotation to quality pharma. Confidence: 3/5 |
| EXIDEIND | 🔴 SELL | Removed from F&O (effective Jul 29). Reduced institutional interest, liquidity contraction. Confidence: 5/5 |
Inference Note
The SEBI PMS consultation paper is a public document. No named companies appear in the consultation paper. The PMS players and AMCs listed above are inferred beneficiaries based on the proposed regulatory changes (overseas investment allowance, MF-PMS category, derivative flexibility). The IT/FMCG stock calls are based on actual market performance and earnings results.